Download PDF
CC BY-NC-ND 4.0 · Neuropediatrics
DOI: 10.1055/a-1949-9310
Original Article

TARS2 variants causes combination oxidative phosphorylation deficiency-21: a case report and literature review

TARS2 variants causes combination oxidative phosphorylation deficiency-21
Xin Gao
1   Department of Pediatric, Inner Mongolia Maternal and Child Health Hospital, Hohhot, China
,
Guoyan Xin
2   Department of Pediatric, Inner Mongolia Maternal and Child Health Hospital, Hohhot, China
,
Ya Tu
2   Department of Pediatric, Inner Mongolia Maternal and Child Health Hospital, Hohhot, China
,
Xiaoping Liang
2   Department of Pediatric, Inner Mongolia Maternal and Child Health Hospital, Hohhot, China
,
Huimin Yang
2   Department of Pediatric, Inner Mongolia Maternal and Child Health Hospital, Hohhot, China
,
Hong Meng
3   Department of Pediatric, Inner Mongolia Maternal and Child Health Hospital, Hohhot, China
,
Yumin Wang 
2   Department of Pediatric, Inner Mongolia Maternal and Child Health Hospital, Hohhot, China
› Author Affiliations
› Further Information
  PDF Download Permissions and Reprints

Abstract Objective: To explore the clinical characteristics and genetic characteristics of the combined oxidative phosphorylation defect type 21 (COXPD21) caused by the TARS2 compound heterozygous varians, and to improve clinicians' awareness of the disease. Methods: The clinical performance, diagnosis and treatment process and gene characteristics of COXPD21 caused by TARS2 were reviewed and analyzed and reviewed combined with the literature. Results: The proband was a girl, the first birth, with repeated refractory hypokalemia, hearing impairment, developmental delay and intellectual disability，development backwardness after infection, high limb muscle tension, and increased serum lactate as the clinical phenotype. Two heterozygous varians in the TARS2 gene were detected by whole exome sequencing, one of which was c.1679(exon14) A > C (p.Asp560Ala) missense , which was derived from the mother, and the other was c.1036(exon10)C >T (p.Arg346Cys) missense variant, derived from the father, the child was diagnosed with COXPD21. The literature collected from the CNKI, Wanfang data and biomedical literature database (PubMed) until November 2021 were searched and reviewed with the key words "mitochondrial encephalomyopathy", "TARS2" and "combined oxidative phosphorylation deficiency type 21". A total of four complete domestic and foreign cases were collected from the literature search. Conclusion: COXPD21 onset by complex heterozygous variant of TARS2 causes refractory hypokalemia, which is rarely reported at home and abroad.



Publication History

Received: 18 April 2022

Accepted after revision: 13 September 2022

Accepted Manuscript online:
23 September 2022

© 2022. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany